Lauren Jessell1, Victoria Stanhope2, Jennifer I Manuel2, Pedro Mateu-Gelabert3. 1. New York University, Silver School of Social Work, 1 Washington Square North, New York, NY 10003, USA. Electronic address: Lj927@nyu.edu. 2. New York University, Silver School of Social Work, 1 Washington Square North, New York, NY 10003, USA. 3. City University of New York, Graduate School of Public Health and Health Policy, 55 W 125th Street, New York, NY 10027, USA.
Abstract
OBJECTIVE: One class of drugs increasingly involved in overdose fatalities is benzodiazepines. Prescribing benzodiazepines to people with co-occurring substance use disorders (SUDs) poses risk for overdose and dependence and is not recommended. The current study reports prevalence rates of prescribing benzodiazepines to people with and without co-occurring SUDs in community mental health settings. Clinical and socio-demographic factors associated with receipt of a benzodiazepine were examined, including whether factors potentially indicative of prescribing biases (older age and race) moderated the relationship between having a co-occurring SUD and receiving a benzodiazepine prescription. METHODS: Retrospective chart review data from service users treated between August 2014 and August 2017 were collected as part of an NIMH-funded RCT of Person-Centered Care Planning. Data were assessed from 774 charts collected across 14 sites nested within ten community mental health centers (CMHCs). Mixed effects logistic regression models examined direct and interaction effects related to receipt of a benzodiazepine. RESULTS: Of the 774 service users, 19.9% (N = 154) were prescribed at least one benzodiazepine. Of those prescribed a benzodiazepine, 35.1% (N = 54) had a co-occurring SUD and 31.8% (N = 49) had an anxiety disorder. Our main effects model did not find a significant difference in the odds of receiving a benzodiazepine among service users with and without a co-occurring SUD (OR = 0.77, CI: 0.50-1.17). However, moderation analyses found that the odds of being prescribed a benzodiazepine among people with co-occurring SUDs was greater among service users of older age (OR: 2.01, CI: 1.01-4.02) and non-Hispanic white race (OR = 3.34, CI: 1.55-7.22). DISCUSSION: Our findings demonstrate that a considerable number of people with a documented co-occurring SUD are prescribed benzodiazepines in CMHCs, a practice that poses risks for dependence and overdose. Prescribing decisions may be influenced by service user age and race.
OBJECTIVE: One class of drugs increasingly involved in overdose fatalities is benzodiazepines. Prescribing benzodiazepines to people with co-occurring substance use disorders (SUDs) poses risk for overdose and dependence and is not recommended. The current study reports prevalence rates of prescribing benzodiazepines to people with and without co-occurring SUDs in community mental health settings. Clinical and socio-demographic factors associated with receipt of a benzodiazepine were examined, including whether factors potentially indicative of prescribing biases (older age and race) moderated the relationship between having a co-occurring SUD and receiving a benzodiazepine prescription. METHODS: Retrospective chart review data from service users treated between August 2014 and August 2017 were collected as part of an NIMH-funded RCT of Person-Centered Care Planning. Data were assessed from 774 charts collected across 14 sites nested within ten community mental health centers (CMHCs). Mixed effects logistic regression models examined direct and interaction effects related to receipt of a benzodiazepine. RESULTS: Of the 774 service users, 19.9% (N = 154) were prescribed at least one benzodiazepine. Of those prescribed a benzodiazepine, 35.1% (N = 54) had a co-occurring SUD and 31.8% (N = 49) had an anxiety disorder. Our main effects model did not find a significant difference in the odds of receiving a benzodiazepine among service users with and without a co-occurring SUD (OR = 0.77, CI: 0.50-1.17). However, moderation analyses found that the odds of being prescribed a benzodiazepine among people with co-occurring SUDs was greater among service users of older age (OR: 2.01, CI: 1.01-4.02) and non-Hispanic white race (OR = 3.34, CI: 1.55-7.22). DISCUSSION: Our findings demonstrate that a considerable number of people with a documented co-occurring SUD are prescribed benzodiazepines in CMHCs, a practice that poses risks for dependence and overdose. Prescribing decisions may be influenced by service user age and race.
Authors: Herbert D Kleber; Roger D Weiss; Raymond F Anton; Tony P George; Shelly F Greenfield; Thomas R Kosten; Charles P O'Brien; Bruce J Rounsaville; Eric C Strain; Douglas M Ziedonis; Grace Hennessy; Hilary Smith Connery; John S McIntyre; Sara C Charles; Daniel J Anzia; Ian A Cook; Molly T Finnerty; Bradley R Johnson; James E Nininger; Paul Summergrad; Sherwyn M Woods; Joel Yager; Robert Pyles; C Deborah Cross; Roger Peele; John P D Shemo; Lawrence Lurie; R Dale Walker; Mary Ann Barnovitz; Sheila Hafter Gray; Sunil Saxena; Tina Tonnu; Robert Kunkle; Amy B Albert; Laura J Fochtmann; Claudia Hart; Darrel Regier Journal: Am J Psychiatry Date: 2007-04 Impact factor: 18.112
Authors: Peggy L O'Brien; Lucy H Karnell; Manjushu Gokhale; B S Kenneth Pack; Melinda Campopiano; Julia Zur Journal: Drug Alcohol Depend Date: 2017-06-20 Impact factor: 4.492